Alosetron Uses, Side Effects & Warnings - Drugs.com
2024年3月25日 · What is alosetron? Alosetron is used to treat severe chronic irritable bowel syndrome (IBS) in women who have diarrhea as their main symptom. Alosetron is given after other treatments did not work or stopped working. Alosetron is …
Alosetron (oral route) - Mayo Clinic
2024年2月1日 · Alosetron works by blocking the action of serotonin on the intestine. This reduces the cramping abdominal pain, abdominal discomfort, urgency (sudden need for a bowel movement), and diarrhea caused by IBS. Alosetron does not cure IBS and may not help every person who takes it.
Alosetron - Wikipedia
Alosetron, sold under the brand name Lotronex among others, is a 5-HT 3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in females only. It was patented in 1987 and approved for medical use in 2002. [2] It is currently marketed by Prometheus Laboratories Inc. .
Alosetron - StatPearls - NCBI Bookshelf
2024年7月2日 · Alosetron is a 5-HT3 receptor antagonist that treats severe diarrhea-predominant irritable bowel syndrome (IBS-D). This educational activity focuses on the indications, mechanism of action, and contraindications associated with alosetron.
Alosetron: MedlinePlus Drug Information
Alosetron is used to treat diarrhea, pain, cramps, and the feeling of an urgent need to have bowel movements caused by irritable bowel syndrome (IBS; a condition that causes stomach pain, bloating, constipation, and diarrhea) in women who have diarrhea as their main symptom and have not been helped by other treatments.
Alosetron HCL - Uses, Side Effects, and More - WebMD
Drugs & Medications. Alosetron HCL - Uses, Side Effects, and More. Common Brand (S): Lotronex. Generic Name (S): alosetron. Uses. Alosetron is used to treat women with severe irritable bowel...
Alosetron: Uses, Interactions, Mechanism of Action | DrugBank ...
Alosetron is a 5-HT3 antagonist used only for the management of severe diarrhoea-predominant irritable bowel syndrome (IBS) in women. Alosetron has an antagonist action on the 5-HT3 receptors and thus may modulate serotonin-sensitive gastrointestinal (GI) processes.